Your browser doesn't support javascript.
loading
Combining plasma-based biosources to predict treatment response in NSCLC patients.
Bracht, J W P; Berenguer, J; Karachaliou, N; Filipska, M; Rosell, R.
Affiliation
  • Bracht JWP; Pangaea Oncology, Laboratory of Molecular Biology, Coyote Research Group, Quirón-Dexeus University Institute, Barcelona.
  • Berenguer J; Pangaea Oncology, Laboratory of Molecular Biology, Coyote Research Group, Quirón-Dexeus University Institute, Barcelona.
  • Karachaliou N; Pangaea Oncology, Laboratory of Molecular Biology, Coyote Research Group, Quirón-Dexeus University Institute, Barcelona.
  • Filipska M; QuironSalud Group, Instituto Oncológico Dr Rosell (IOR), University Hospital Sagrat Cor, Barcelona.
  • Rosell R; Institut d'Investigació en Ciències Germans Trias i Pujol, Badalona.
Ann Oncol ; 29(9): 2022, 2018 09 01.
Article in En | MEDLINE | ID: mdl-30010765
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Circulating Tumor DNA / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Circulating Tumor DNA / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Year: 2018 Document type: Article